Trends and challenges in biosimilars pricing and reimbursement policies in Europe and beyond

Author(s): Alessandro Curto, MSSc

Abstract: Biosimilars policies are more controversial than those for generics. However, it is only a question of time before progress in biosimilars matches that of generics worldwide. Submitted: 21 April 2017; Revised: 28 April 2017; Accepted: 2 May 2017; Published online first: 15 May 2017 Healthcare systems worldwide are under increasing pressure due to the […]

Read more →